ADAM10 and pemphigus: To test whether the protective effect of ADAM10 inhibition depends on the amount of autoantibodies targeting Dsg3, we performed dissociation assays with AK23, a pathogenic monoclonal Dsg3 autoantibody derived from a pemphigus mouse model (46).